Articles On Paragon Care (ASX:PGC)

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Japanese beer giant Kirin becomes substantial shareholder of Blackmores after $1.2 takeover bid State Street Corporation becomes substantial shareholder of Gold Road Resources as gold prices rallies State Street Corporation sells out of Sa...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

A handful of ASX biotechs are entering their crucial stages of development Promising outlooks for PharmAxis, Botanix Pharma, and Paragon Care   Pharmaxis could surge if FDA application successful Broker Taylor Collison sees an Outperform...

ShareCafeUS regional banks slammed as SVB saga continues                    The Dow Jones Industrial Average dropped on Monday as a plan to backstop all the depositors in failed Silicon Valley Bank, along with other extraordinary meas...

Some of the smaller ASX dividend shares could be contenders for good dividends and growth in the future. I think one name to consider is Paragon Care Ltd (ASX: PGC). After going through a difficult period over the last few years, the ASX h...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

ShareCafeStocks rise as bond yields fall: All eyes on RBA rate decision today                    Stocks rallied Monday for the start to the new month and quarter, as Treasury yields eased from levels not seen in roughly a decade. The...

ShareCafeKey week for US economic data as indexes produce strong weekly gains                    US equities were higher in Friday trading, finishing just off best levels. Each of the major averages were up more than 2.5 per cent for...

ShareCafeLunch Report: 25 August, 2022 by Paul Sanger   At noon, the S&P/ASX 200 is 0.68 per cent or 47.40 points higher at 7045.50. The SPI futures are pointing to a rise of 56 points Best and worst performers The best-performing secto...

ShareCafeStocks of the Hour: 25 August, 2022                    Bulletin Resources (ASX:BNR) today provided an update on its Ravensthorpe Lithium Project. The project is located only 12km southwest, along the strike of Allkem Limited’...

25 Aug 2022 - A snapshot of the stocks on the move featuring Bulletin Resources (ASX:BNR), Paragon Care (ASX:PGC) and Magnis Energy Technologies (ASX:MNS).

The ASX 200 will open higher on Thursday The gathering of world central bankers in Wyoming begins today US time European gas prices rise again ahead of pipeline maintenance work Local shares are set to open higher today. At 8am AEST, the...

ShareCafeEvening Report: 26 July, 2022 by Paul Sanger   The S&P/ASX 200 closed marginally higher on Tuesday in a reasonably quiet trading session as investors prepare themselves for the busiest week of corporate earnings in the US and W...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Highlights 5 ASX-listed companies Adairs Limited (ASX:ADH), Apiam Animal Health Ltd (ASX:AHX), K&S Corporation Limited (ASX:KSC), NRW Holdings Limited (NWH), and Paragon Care Ltd (ASX:PGC), turned ex-dividend today.    The share...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Careteq (CTQ) fell flat on its ASX debut today, with shares trading down 25 per cent on the IPO issue price of 20cents – shares traded at 16 cents at the market close Through its IPO, Careteq issued 30 million shares, raising $6 million, i...

Highlights Careteq is slated to list on the ASX on Monday (10/01/22) at 11AM. Funds raised from the IPO will be used to fast-track growth of its Assistive Living Technology solution globally to disrupt the large aged and disability car...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

Paragon Care (PGC) has appointed Mark Hooper as group chief executive officer (CEO) and managing director of the company Mark Hooper is the current CEO of Sigma Healthcare, announcing his tendered resignation after almost 11 years Over the...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Paragon Care (PGC) has entered into a partnership with Centuria Healthcare for the 15-year lease of a state-of-the-art healthcare facility in Melbourne Located in the Monash precinct, the property features clean room facilities, laboratori...

The ASX 200 Health Index (XHJ) is down by 0.70% at the time of writing, compared to the broader index which is down by 0.55%. Health tech MedAdvisor (ASX:MDR) held its AGM this morning, in which it outlined the company’s strategic prioritie...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Healthcare stocks Paragon Care (PGC) and Quantum Health Group (QTM) have announced they will merge to create a single medical supplies business Under the scheme of arrangement deed, Paragon will acquire 100 per cent of Quantum shares, with...

Medical equipment and devices company Paragon Care is set to merge with medical imaging and equipment business Quantum Health Group in an all scrip deal.

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

The Paragon Care Ltd (ASC: PGC) share price is in the green today after the company released its earnings for financial year 2021 (FY21).  Right now, the Paragon share price is 30 cents, 5.26% higher than its previous close. Paragon Care s...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

The Victorian state government handed down its budget today with billions in new taxes and cuts that will create winners and losers among ASX shares. Victorian Treasurer Tim Pallas has gone in the opposite direction of his federal counterp...

Summary Biopharmaceutical company Bionomics Limited will expand its product pipeline for the treatment of Social Anxiety Disorder (SAD). The Company disclosed that the rapid oral absorption of the novel tablet formulation of BNC210 is...

Summary The TLM share price has skyrocketed by 19.3% to AU$0.185 in today’s session. PGC announced it has successfully renegotiated its banking facilities have been with NAB. On Friday, MGT received binding commitments to raise up to...

The Paragon Care Ltd (ASX: PGC) share price is flying today following two exciting updates from the company. At the time of writing, the Paragon share price is 19% higher than its previous close, with shares in the company trading for 25 c...

Summary Oncology player Telix Pharmaceuticals has commenced Phase 3 clinical trial of its prostate cancer therapy candidate. Polymer implants manufacturer Osteopore Limited has obtained CE certification for a significantly broader rang...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...